Severe Primary Hand Hyperhidrosis clinical trials

Explore recruiting severe primary hand hyperhidrosis clinical trials.

Also recruiting in Europe

Severe Primary Hand Hyperhidrosis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A phase 2, randomised, double-blind, vehicle-controlled, dose finding, efficacy, tolerability and safety study of Victorhy in patients with severe hand hyperhidrosis

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Severe Primary Hand Hyperhidrosis trials by city

Severe Primary Hand Hyperhidrosis in Toronto Severe Primary Hand Hyperhidrosis in Vancouver Severe Primary Hand Hyperhidrosis in Montreal Severe Primary Hand Hyperhidrosis in Calgary Severe Primary Hand Hyperhidrosis in Edmonton Severe Primary Hand Hyperhidrosis in Ottawa Severe Primary Hand Hyperhidrosis in Winnipeg Severe Primary Hand Hyperhidrosis in Quebec City Severe Primary Hand Hyperhidrosis in Hamilton Severe Primary Hand Hyperhidrosis in Kitchener Severe Primary Hand Hyperhidrosis in London Severe Primary Hand Hyperhidrosis in Halifax Severe Primary Hand Hyperhidrosis in New York Severe Primary Hand Hyperhidrosis in Los Angeles Severe Primary Hand Hyperhidrosis in Chicago Severe Primary Hand Hyperhidrosis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease